£62.49

It has never been this cheap. We have no record of a lower price.

£62 today · cheaper than every other day in the last 1 months

Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£62.49 £59.37 £60.62 £61.87 £63.11 £64.36 £65.61 10 September 2026 14 September 2026 19 September 2026 24 September 2026 29 September 2026
View at Amazon ↗

Price data last checked 22 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £62 Days at Price

Price Analysis

Most common price: £62 (20 days, 100.0%)

Price range: £62 - £62

Price levels: 1 different prices over 20 days

Description

As Guest Editor, I have the pleasure of sharing a Special Issue of Cancers entitled "Novel Biomarkers in Non-Small Cell Lung Cancer (NSCLC)". This collection includes 10 original articles written by internationally recognized experts in this field. Recent progress in molecular characterization, in addition to a better understanding of the tumor immune context, has been dramatically changing the course of NSCLC patient care. At the same time, the advent of targeted therapies and immunotherapies has been driven by the expanding number of biomarkers that help predict sensitivity to these novel agents. In fact, identifying patients that are most likely to benefit from targeted therapy or immunotherapy is essential in order to optimize treatment outcomes while minimizing the risks of overtreatment or undertreatment. For these reasons, currently, all patients with advanced NSCLC require not only accurate staging but also comprehensive molecular profiling, including an assessment of several biomarkers. This Special Issue offers an overview concerning the latest advancements in NSCLC biomarker research, with a focus on technologies that are needed for their detection and use in clinical practice.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
12 February 2026
Listed Since
10 March 2026

Barcode

No barcode data available

Similar Products You Might Like

Translational and Comparative Research on Innovative Anti-Cancer Therapies
86% match

Translational and Comparative Research on Innovative Anti-Cancer Therapies

£65.36 16 Sep 2026
Novel Anticancer Strategies
83% match

Novel Anticancer Strategies

£76.61 16 Sep 2026
Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer
83% match

Diagnostic, Prognostic and Predictive Biomarkers in Prostate Cancer

MDPI AG

£64.85 29 Aug 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
83% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£66.33 05 Aug 2026
Molecular Targeted Therapy of Lung Cancer
83% match

Molecular Targeted Therapy of Lung Cancer

Springer

£113.79 08 Aug 2026
Cancer Prevention with Molecular Target Therapies 4.0
83% match

Cancer Prevention with Molecular Target Therapies 4.0

£61.85 29 Aug 2026
Metal Nanoparticles for Cancer Therapy
83% match

Metal Nanoparticles for Cancer Therapy

£75.81 15 Sep 2026
Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer
82% match

Advances in Cancer Therapy from Research to Clinical Practice: Surgical, Molecular or Systemic Management of Cancer

£64.26 14 Sep 2026
Malignant Mesothelioma
82% match

Malignant Mesothelioma

£54.50 16 Sep 2026
Advancements in Lung Cancer Surgical Treatment and Prognosis
82% match

Advancements in Lung Cancer Surgical Treatment and Prognosis

£62.50 23 Aug 2026
Advances in the Treatment of Renal Cell Carcinoma
82% match

Advances in the Treatment of Renal Cell Carcinoma

£41.90 14 Sep 2026
Advances in Molecular Mechanisms of Gastrointestinal Tumors
82% match

Advances in Molecular Mechanisms of Gastrointestinal Tumors

£58.69 14 Sep 2026
Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)
81% match

Biology and Management of Lung Cancer: 11 (Cancer Treatment and Research)

Springer

£169.56 06 Aug 2026
Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice
81% match

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Springer

£80.67 05 Aug 2026
Management of Pancreatic Cancer
81% match

Management of Pancreatic Cancer

£80.06 22 Aug 2026
Roles of NF-ΚB in Cancer and Their Therapeutic Approaches
81% match

Roles of NF-ΚB in Cancer and Their Therapeutic Approaches

MDPI AG

£55.53 31 Aug 2026
Cancer Biomarkers
81% match

Cancer Biomarkers

£64.99 15 Sep 2026
Endocrine and Neuroendocrine Cancers
81% match

Endocrine and Neuroendocrine Cancers

£51.92 23 Aug 2026
In Vitro and In Vivo Models of Colorectal Cancer for Clinical Application
81% match

In Vitro and In Vivo Models of Colorectal Cancer for Clinical Application

£52.21 14 Sep 2026
The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
80% match

The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy

£54.50 16 Sep 2026
Advances and Novel Treatment Options in Metastatic Melanoma
80% match

Advances and Novel Treatment Options in Metastatic Melanoma

£75.66 16 Sep 2026
Novel Therapeutic Approaches for Cancer Treatment
80% match

Novel Therapeutic Approaches for Cancer Treatment

£95.56 22 Aug 2026
Advances in the Treatment of Kidney and Upper Urinary Tract Cancers
80% match

Advances in the Treatment of Kidney and Upper Urinary Tract Cancers

£52.78 15 Sep 2026
Oncogenesis of Lymphoma
80% match

Oncogenesis of Lymphoma

£70.75 27 Aug 2026